White Papers

Merck Determines Microsoft Windows Rights Management Services Improves Confidentiality of Clinical Trial Information

Overview Information confidentiality is of critical importance to pharmaceutical firms. During clinical trials, Merck & Co., Inc., a leading world-wide pharmaceutical products and services company, exchanges sensitive information with participating partner physicians. This poses a security challenge because Merck must make every effort to protect the confidentiality of the information during transmission as well as after it is in the physicians' possession. Microsoft Windows Rights Management Services (RMS) for Microsoft Windows Server 2003 offers the perfect solution to meet Merck's challenge. Without RMS, Merck delivers only hardcopy documents via express couriers to physicians. With RMS, documents continue to be protected even after delivery.

Further White Paper Details
PublisherMicrosoft File FormatHTML
Date PublishedFebruary 2007
FormatCase Studies   
Topics
    N/A

Quick Sitemap Links: